Literature DB >> 29256319

Antibody response to feline panleukopenia virus vaccination in healthy adult cats.

Michèle Bergmann1, Stephanie Schwertler1, Sven Reese2, Stephanie Speck3, Uwe Truyen3, Katrin Hartmann1.   

Abstract

OBJECTIVES: According to prior studies, between 25.0% and 92.8% of adult cats have antibodies against feline panleukopenia virus (FPV) and thus are likely protected against FPV infection. It is, however, unknown how healthy adult cats with different antibody titres react to FPV vaccination in the field. Therefore, the aim of the study was to measure antibody titres in healthy adult cats within a period of 28 days after vaccination against FPV and to evaluate factors that are associated with a lack of adequate response to vaccination.
METHODS: One hundred and twelve healthy adult cats were vaccinated with a vaccine against FPV, feline herpesvirus and feline calicivirus. Antibodies against FPV were determined before vaccination (day 0), on day 7 and day 28 after vaccination by haemagglutination inhibition (HI). A HI titre ⩾1:40 was defined as protective. An adequate response to vaccination was defined as a four-fold titre increase. Uni- and multivariate statistical analysis was used to determine factors associated with an adequate response.
RESULTS: Pre-vaccination antibody titres of ⩾1:40 were present in 64.3% (72/112; 95% confidence interval [CI] 55.1-72.6). Only 47.3% (53/112; 95% CI 37.8-57.0) of cats had an adequate response to vaccination. Factors associated with an adequate response to vaccination were lack of previous vaccination (odds ratio [OR] 15.58; 95% CI 1.4-179.1; P = 0.035), lack of antibodies (⩾1:40) prior to vaccination (OR 23.10; 95% CI 5.4-98.8; P <0.001) and breed (domestic shorthair cats; OR 7.40; 95% CI 1.4-38.4; P = 0.017). CONCLUSIONS AND RELEVANCE: As none of the cats with high pre-vaccination antibody titres (⩾1:160) had an at least four-fold increase in FPV antibody titres, measurement of antibodies rather than regular revaccinations should be performed. Thus, evaluation of FPV antibody titre in cats with previous vaccinations against FPV are recommended prior to revaccination.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29256319     DOI: 10.1177/1098612X17747740

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  11 in total

1.  Prevalence of protective feline panleukopenia antibody titers detected by a point-of-care enzyme-linked immunosorbent assay in cats presenting to a university emergency service.

Authors:  Kimberly Golden; Elizabeth Rozanski; Sam Rizika; Ian DeStefano
Journal:  Can J Vet Res       Date:  2022-07       Impact factor: 0.897

2.  Distinct Lineages of Feline Parvovirus Associated with Epizootic Outbreaks in Australia, New Zealand and the United Arab Emirates.

Authors:  Kate Van Brussel; Maura Carrai; Carrie Lin; Mark Kelman; Laura Setyo; Danielle Aberdein; Juliana Brailey; Michelle Lawler; Simone Maher; Ildiko Plaganyi; Emily Lewis; Adele Hawkswell; Andrew B Allison; Joanne Meers; Vito Martella; Julia A Beatty; Edward C Holmes; Nicola Decaro; Vanessa R Barrs
Journal:  Viruses       Date:  2019-12-13       Impact factor: 5.048

3.  Feline Panleukopenia Outbreaks and Risk Factors in Cats in Animal Shelters.

Authors:  Teresa Rehme; Katrin Hartmann; Uwe Truyen; Yury Zablotski; Michèle Bergmann
Journal:  Viruses       Date:  2022-06-08       Impact factor: 5.818

4.  Antibody Response to Feline Calicivirus Vaccination in Healthy Adult Cats.

Authors:  Michèle Bergmann; Stephanie Speck; Anna Rieger; Uwe Truyen; Katrin Hartmann
Journal:  Viruses       Date:  2019-07-31       Impact factor: 5.048

5.  Feline Parvovirus Seroprevalence Is High in Domestic Cats from Disease Outbreak and Non-Outbreak Regions in Australia.

Authors:  Elizabeth Jenkins; Conor Davis; Maura Carrai; Michael P Ward; Susan O'Keeffe; Martine van Boeijen; Louise Beveridge; Costantina Desario; Canio Buonavoglia; Julia A Beatty; Nicola Decaro; Vanessa R Barrs
Journal:  Viruses       Date:  2020-03-16       Impact factor: 5.048

6.  Construction and Immunogenicity of Virus-Like Particles of Feline Parvovirus from the Tiger.

Authors:  Cuicui Jiao; Hongliang Zhang; Wei Liu; Hongli Jin; Di Liu; Jian Zhao; Na Feng; Chuanmei Zhang; Jing Shi
Journal:  Viruses       Date:  2020-03-16       Impact factor: 5.048

7.  Antibody Response to Canine Adenovirus-2 Virus Vaccination in Healthy Adult Dogs.

Authors:  Michèle Bergmann; Monika Freisl; Yury Zablotski; Stephanie Speck; Uwe Truyen; Katrin Hartmann
Journal:  Viruses       Date:  2020-10-21       Impact factor: 5.048

8.  Prevalence of Neutralizing Antibodies to Canine Distemper Virus and Response to Vaccination in Client-Owned Adult Healthy Dogs.

Authors:  Michèle Bergmann; Monika Freisl; Yury Zablotski; Md Anik Ashfaq Khan; Stephanie Speck; Uwe Truyen; Katrin Hartmann
Journal:  Viruses       Date:  2021-05-20       Impact factor: 5.048

9.  Modified-Live Feline Calicivirus Vaccination Elicits Cellular Immunity against a Current Feline Calicivirus Field Strain in an Experimental Feline Challenge Study.

Authors:  Andrea M Spiri; Marilisa Novacco; Marina L Meli; Martina Stirn; Barbara Riond; Jonathan E Fogle; Felicitas S Boretti; Imogen Herbert; Margaret J Hosie; Regina Hofmann-Lehmann
Journal:  Viruses       Date:  2021-08-31       Impact factor: 5.048

10.  Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax® FIV).

Authors:  Mark Westman; Dennis Yang; Jennifer Green; Jacqueline Norris; Richard Malik; Yasmin A Parr; Mike McDonald; Margaret J Hosie; Sue VandeWoude; Craig Miller
Journal:  Viruses       Date:  2021-03-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.